NEW YORK, October 25, 2024 – PRISM MediaWire – Bubblr Inc., d/b/a Ethical Web AI (OTC: BBLR) – a frontrunner in ethical technology determined to
CAPE CANAVERAL, FL, October 24, 2024 – PRISM MediaWire – Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), an innovative, agile space mission enabler, today
ENGLEWOOD, Colo., October 24, 2024 – PRISM MediaWire – XTI Aerospace, Inc. (NASDAQ: XTIA) (“XTI Aerospace” or the “Company”) today announced that it will be
BranchOut Peru Facility Now Operational, Driving Profitability Through High-Margin Production Key Highlights: BEND, Ore., October 24, 2024 – PRISM MediaWire – BranchOut Food Inc. (NASDAQ:
EDEN PRAIRIE, Minn., October 24, 2024 – PRISM MediaWire – NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused
Princeton, NJ, October 24, 2024 – PRISM MediaWire – Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and
Discoverer of Klotho gene further strengths KLTO Scientific Advisory Board New York, NY, October 23, 2024 – PRISM MediaWire – Klotho Neurosciences, Inc. (NASDAQ: KLTO),
Glen Allen, VA, October 23, 2024 – PRISM MediaWire – Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on
Presentation on October 30 at 4 p.m. ET, and Attend 1×1 Meetings Vancouver, BC, October 23, 2024 – PRISM MediaWire – Siyata Mobile Inc. (Nasdaq:
MIAMI, FL., October 23, 2024 – PRISM MediaWire – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, (“NRx,” the “Company”) and HOPE Therapeutics, Inc.,
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
